CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $) In Thousands	9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Cash flows from operating activities:
Net income (loss) attributable to Nabors	$ 349,529	$ 44,214
Adjustments to net income (loss):
Depreciation and amortization	686,820	547,399
Depletion and other exploratory expenses	31,949	24,587
Deferred income tax expense (benefit)	61,566	53,622
Deferred financing costs amortization	4,000	3,760
Pension liability amortization and adjustments	450	298
Discount amortization on long-term debt	26,546	53,818
Amortization of loss on hedges	695	464
Impairments and other charges	98,072	123,099
Losses (gains) on long-lived assets, net	(40,636)	(3,242)
Losses (gains) on investments, net	(8,567)	4,659
Losses (gains) on debt retirement, net	58	7,042
Losses (gains) on derivative instruments	267	2,473
Gain on acquisition	(12,178)
Share-based compensation	17,249	10,602
Foreign currency transaction losses (gains), net	743	16,795
Equity in (earnings) losses of unconsolidated affiliates, net of dividends	(135,844)	(14,494)
Changes in operating assets and liabilities:
Accounts receivable	(283,082)	(140,592)
Inventory	(76,913)	(7,779)
Other current assets	(2,623)	(117,599)
Other long-term assets	79,770	492
Trade accounts payable and accrued liabilities	331,633	40,605
Income taxes payable	(466)	43,458
Other long-term liabilities	(20,904)	(11,547)
Net cash provided by operating activities	1,108,134	682,134
Cash flows from investing activities:
Purchases of investments	(9,567)	(27,695)
Sales and maturities of investments	24,580	32,103
Cash paid for acquisition of businesses, net	(55,459)	(680,230)
Investment in unconsolidated affiliates	(54,762)	(40,936)
Distribution of proceeds from asset sales from unconsolidated affiliates	142,984
Capital expenditures	(1,532,597)	(640,953)
Proceeds from sales of assets and insurance claims	110,535	26,084
Net cash used for investing activities	(1,374,286)	(1,331,627)
Cash flows from financing activities:
Increase (decrease) in cash overdrafts	5,074	(4,649)
Proceeds from issuance of long-term debt	697,578	691,281
Proceeds from issuance of common shares	12,175	5,391
Proceeds from revolving credit facilities	1,300,000	600,000
Debt issuance costs	(6,065)	(7,144)
Reduction in long-term debt	(1,404,271)	(314,353)
Reduction in revolving credit facilities	(700,000)	(600,000)
Repurchase of equity component of convertible debt	(12)	(4,712)
Settlement of call options and warrants, net		1,134
Purchase of restricted stock	(2,579)	(1,904)
Tax benefit related to share-based awards	185	(38)
Net cash (used for) provided by financing activities	(97,915)	365,006
Effect of exchange rate changes on cash and cash equivalents	(2,174)	(3,645)
Net (decrease) increase in cash and cash equivalents	(366,241)	(288,132)
Cash and cash equivalents, beginning of period	641,702	927,815
Cash and cash equivalents, end of period	$ 275,461	$ 639,683